CDC & AHVAP Top Priorities:
Optimize blood culture orders
Prevent blood culture contamination
Ensure appropriate blood volume

Learn more
Introducing Kurin Jet^™
The fastest way to sideline
blood culture contaminants.

Learn more

News

{"ticker_effect":"slide-h","autoplay":"true","speed":"4000","font_style":"normal"}

Need more information?
Click here to connect with Kurin.

Kurin Blood Culture Collection Sets

Clinically proven and FDA indicated for reducing blood culture contamination.*

Click here to view 510(k) clearances for all Kurin product codes.

Kurin Lock^® blood culture collection sets passively sideline the initial 0.15ml of blood, which may contain contaminants from the patient’s own skin, ensuring that the best possible blood specimen reaches the collection bottles.

Studies show compliance with best practice combined with Kurin technology to sideline the initial flash of blood can reduce contaminated cultures by more than 80%, improving the clinical value of blood culture testing for safer, more effective, and lower cost treatment of patients.

Learn more

Battling false-positive blood cultures

Bloodstream infection diagnosis is critical to the wellbeing of patients and the financial health of hospitals.

Each year, millions of blood culture tests occur, though the majority will find no infection.¹ Of the cultures that test positive, almost 33% are FALSE-positive results caused by contamination.

Roughly 20% of the skin microbes reside deep in the dermis layer and may be drawn into blood samples.² Unavoidable until now, hospitals have accepted the consequences of high rates of false positive results.

Learn more

Just like the boy who cried wolf, high numbers of false positive results lead to inappropriate treatment and cause physicians to question the test. Hear experts explain the consequences of blood culture contamination.
Watch video

Centers for Disease Control and Prevention

In offering guidance, the CDC references a study by Doern et al which identifies ways to address blood culture contamination. Among the preventive actions, the CDC authors call for the use of diversion devices saying, “There are devices that are commercially available that have shown promise in further reducing blood culture contamination rates. These devices initially divert a small amount of potentially contaminated blood and then collect blood for the blood culture.”

Read the full guidance: Blood Culture Contamination: An Overview for Infection Control and Antibiotic Stewardship Programs Working with the Clinical Laboratory

Resources to learn more

Kurin in Action

Best Practices

BetterBlood
Cultures.com

Kurin Studies

Clinical Evidence

Clinical Guidelines

*The Kurin Blood Collection System is for use as a blood collection system and its Kurin Lock allows the specimen of blood from the patient to be sidelined prior to the collection of the test sample to reduce the frequency of blood culture contamination when contaminates are present in the initial blood sample compared to blood cultures drawn using standard practice without the Kurin Lock. [FDA 510(k) Indication Number K220677]

REFERENCES:
¹ Zwang O, Albert RK. J Hosp Med. 2006 Sep;1(5):272-6.
² Garcia RA, Spitzer ED, Beaudry J, et al. Am J Infect Control. 2015 Nov 1;43(11):1222-37.

ML-008 Rev I